Athira Pharma
Stock Forecast, Prediction & Price Target
Athira Pharma Financial Estimates
Athira Pharma Revenue Estimates
Athira Pharma EBITDA Estimates
Athira Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $4.47M Low: $4.47M High: $4.47M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% |
Net Income
% change YoY
| $-54.37M N/A | $-87.26M -60.48% | $-117.67M -34.84% | Avg: $-126.96M Low: $-134.21M High: $-36.11M avg. -7.89% | Avg: $-146.23M Low: $-135.73M High: $-28.51M avg. -15.17% | Avg: $-34.21M Low: $-34.21M High: $-34.21M avg. 76.60% | Avg: $-16.72M Low: $-16.72M High: $-16.72M avg. 51.11% |
EBITDA
% change YoY
| $-55.18M N/A | $-78.85M -42.88% | $-116.70M -47.99% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.47 N/A | -$2.31 -57.14% | -$3.1 -34.19% | Avg: -$2.22 Low: -$3.53 High: -$0.95 avg. 28.54% | Avg: -$1.7 Low: -$3.57 High: -$0.75 avg. 23.40% | Avg: -$0.9 Low: -$0.9 High: -$0.9 avg. 46.95% | Avg: -$0.44 Low: -$0.44 High: -$0.44 avg. 51.11% |
Operating Expenses
% change YoY
| $55.18M N/A | $88.85M 61.00% | $125.46M 41.20% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Athira Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 26.15% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -134.21M, average is -126.96M and high is -36.11M.
What is Athira Pharma stock revenue growth forecast?
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Athira Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 37.50% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$3.53, average is -$2.22 and high is $-0.95.
What is the best performing analyst?
In the last twelve months analysts have been covering Athira Pharma stock. The most successful analyst is Andrew Tsai whose win rate is 100%. He has correctly predicted 1/1 price targets.